UNSPSC 51143001: Imuracetam

This classification denotes a neuroprotective agent with the molecular formula C11H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 972FNV35ZM, chemically known as 1,3-bis((2-oxo-1-pyrrolidinyl)methyl)harnstoff but generally known as imuracetam, which bears US NIH Compound Identifier 163319. European Medicines Agency schedules Imuracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08161MIG.

UNSPSC 51143001 Imuracetam, a Commodity code, covers procurement of the pharmaceutical product imuracetam — a racetam-derivative nootropic agent used in clinical and institutional settings. State and local governments acquire imuracetam primarily through health departments, corrections agencies, state hospital systems, and public health programs for patient care, cognitive support, and clinical trial applications where indicated. The product is procured as a finished pharmaceutical in tablet, capsule, or injectable form, typically through competitive bidding against established wholesalers, group purchasing organizations, and licensed pharmaceutical distributors.

The source provides no recent state and local contract opportunities tagged to this code, making it difficult to characterize the current issuing-body mix, geographic concentration, or representative recent solicitations. The absence of posted opportunities under this Commodity code may reflect procurement through standing contracts, cooperative purchasing agreements, or direct vendor relationships rather than open competitive notice, or may indicate limited current demand for imuracetam in the state and local procurement market. Business development professionals should verify whether jurisdictions in their target regions are actively soliciting this product or whether access is managed through group purchasing vehicles such as state pharmaceutical cooperative contracts.